1 0

    FDA Review Package for Naltrexone (ANDA 213195)

    FDA Review Package for Naltrexone (ANDA 213195)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: ADMINISTRATIVE AND CLINICAL REVIEW PACKAGE FOR NALTREXONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION, ANDA 213195.
    Tags: Pharma, ANDA, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details